Low Strength Antipsychotic Prescribing in Dementia: A GP ...

GMMMG – championing the appropriate use of medicines across Greater Manchester PAGE | 4 AIM AIM To aid the primary care review of low strength antipsychotic prescribing in dementia patients.

  Prescribing, Antipsychotic, Dementia, Strength, Low strength antipsychotic prescribing in dementia

Rufinamide (Inovelon® ) in the treatment of seizures ...

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES Date of original recommendation: 22nd June 2010 Date Re-reviewed: 21st October 2014 Rufinamide (Inovelon® ) in the treatment of seizures

FreeStyle Libre Flash Glucose Monitoring System.

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES November 2017 FreeStyle Libre Flash Glucose Monitoring System. The Formulary and Managed Entry Subgroup discussed the above at its

  System, Monitoring, Flash, Glucose, Libre, Freestyle, Freestyle libre flash glucose monitoring system

NTS recommendation Brimonidine gel for acne …

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th June 2014 Brimonidine (Mirvaso® ) gel for the treatment of acne rosacea erythema. The New Therapies Subgroup (NTS) discussed the above drug at a

  Brimonidine, Brimonidine gel

Tapentadol (Palexia®) prolonged and immediate …

November 2015 Tapentadol (Palexia®) prolonged and immediate release tablets for the treatment of acute and chronic severe pain. The New Therapies Subgroup of the Greater Manchester Medicines

  Release, Tablets, Immediate, Prolonged, Tapentadol, Prolonged and immediate release tablets

Hydrocortisone modified release tablet …

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th April 2014 Hydrocortisone modified release tablet (Plenadren®) for the treatment of adrenal …

  Adrenal

Chapter 4. Central Nervous System - GMMMG

Greater Manchester Joint Formulary Return to contents page V6.6 Page 6 of 32

  System, Chapter, Central, Chapter 4, Nervous, Central nervous system

GMMMG COPD Formulary Inhaler Options September 2018 ...

GMMMG COPD Formulary Inhaler Options – September 2018 Produced by Regional Drug and Therapeutics Centre (RDTC) for the GMMMG. September 2018 BNF 3.1.2 – Antimuscarinic bronchodilators (LAMA) 1st choice Alternatives Tiotropium Aclidinium Glycopyrronium Umeclidinium

Non-pharmacological management for ALL patients

6 Treatment of new COPD patients FEV 1 Spirometry (measuring FEV 1 and FVC) is needed to make the diagnosis of COPD. FEV 1 can be used to measure worsening or improvement in patients.

  Copd

Cost Comparison Charts - GMMMG

Regional Drug and Therapeutics Centre Cost comparison charts 2 Jul 2019

  Chart, Comparison, Cost, Cost comparison charts

The Appropriate Use of Rescue Packs

Primary Care Respiratory UPDATE Before considering prescribing a rescue pack, Dr Hurst says the clini-cian must first make sure that all the high value interventions for COPD have been employed to reduce the risk and consequences of exacer-bations. These include smoking cessation, influenza vaccination, pneu-

  Care, Prescribing, Smoking

VA/DoD Major Depressive Disorder Clinical Practice …

decision making. They are not intended to define a standard of care and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. This Clinical Practice Guideline is based on a systematic review of both clinical and epidemiological evidence.

  Guidelines, Practices, Clinical, Care, Prescribing, Disorders, Major, Clinical practice guidelines, Depressive, Major depressive disorder clinical practice

Healing the Addicted Brain - National Association of ...

2 Credentials • Author of The New York Times best seller, Healing the Addicted Brain • Board certified in addiction and general psychiatry by the American Board of Medical Specialties • Published work in the areas of opiate dependence, alcohol dependence, cocaine dependence and anti-addiction medications • Education: Cum Laude with a Bachelor of Arts in Neuropsychology …